纳武利尤单抗联合伊匹木单抗一线治疗非小细胞肺癌的疗效
Efficacy of Nivolumab plus Ipilimumab as First-Line Treatment in Non-Small-Cell Lung Cancer
纳武利尤单抗联合伊匹木单抗一线治疗非小细胞肺癌的疗效 |
|
评价者:董晓荣 |
Efficacy of Nivolumab plus Ipilimumab as First-Line Treatment in Non-Small-Cell Lung Cancer |
| |